The Th2 cytokines seen in asthma, especially IL-4 and IL-13, may downregulate the Th1 immune response, potentially offering a protective mechanism against COVID-19 and could provide an explanation as to why asthmatic patients infected with SARS-CoV-2 have better disease outcomes. The gene discussed is IL4; the disease is asthma.